Bali hosts the first ISSCA Signature experience, combining advanced cellular therapeutics, immuno-oncology, and a more personal certification format.
From November 2–4, 2026, the International Society for Stem Cell Application (ISSCA) will present ISSCA Signature Bali, a three-day certification experience built around one focused academic program.
The Bali edition introduces ISSCA Signature, a format designed to bring a complete certification to one city at a time. Instead of multiple simultaneous tracks, the program follows a single learning path across three days, allowing participating physicians to remain focused on the scientific principles, clinical context and responsible application of the subjects covered.
ISSCA Signature — Bali will take place at Jl. Sunset Road No. 101E, Kuta, Bali. The program begins at 10:00 AM on November 2.
What is ISSCA Signature?
ISSCA Signature is a city-based certification format that complements ISSCA’s international congresses.
While the ISSCA Global Summit brings together a broad scientific program with several certifications and conference sessions, each Signature edition concentrates on one certification and one continuous educational experience.
Bali is the first city to host this format. The model is designed to travel internationally under a consistent naming system: ISSCA Signature followed by the host city.
This allows each edition to become part of a recognizable global series while keeping its academic focus specific to the certification being delivered.
ISSCA Launches Advanced Peptide Certification 2.0 with two new reference books
Advanced Cellular Therapeutics and Immuno-Oncology Certification
The Bali program is planned as the Advanced Cellular Therapeutics & Immuno-Oncology Certification.
Its curriculum connects cellular science, immune-system principles and emerging therapeutic approaches within a structured program created for physicians.
Across the three-day certification, the academic scope includes:
- Peptide therapy and its place within contemporary regenerative and longevity medicine.
- MUSE cell technology and the scientific principles behind multilineage-differentiating stress-enduring cells.
- Cancer immunology and the relationship between the immune system and tumor biology.
- Dendritic cell approaches within immunological education.
- NK Cell approaches and their relevance to immune surveillance.
These areas will be presented as professional medical education. Participation and certification do not replace local licensing requirements, applicable regulations, product-specific evidence, clinical judgment or patient-specific decision-making.
Why combine cellular therapeutics and immuno-oncology?
Cellular therapeutics and immuno-oncology are increasingly discussed together because both require physicians to understand how cells communicate, respond to stress and interact with the immune environment.
A focused certification can help participants organize these concepts within one academic framework instead of studying each subject in isolation.
The program’s integrated structure is particularly relevant for physicians following developments in regenerative medicine, immune modulation and cell-based science.
It is designed to strengthen conceptual understanding and encourage the responsible evaluation of evidence, safety considerations and clinical context.
Who is the ISSCA Signature Bali certification designed for?
ISSCA Signature Bali is designed for licensed physicians seeking advanced education in cellular therapeutics and immuno-oncology.
The program may be relevant to professionals working in regenerative medicine, longevity medicine, integrative medicine, oncology-related fields and other areas in which cellular and immune science informs clinical practice.
Because regulations and permitted clinical uses differ between countries and jurisdictions, physicians remain responsible for practicing within their professional scope and complying with all applicable local requirements.
ISSCA Signature Bali 2026: dates and location
Event: ISSCA Signature — Bali
Certification: Advanced Cellular Therapeutics & Immuno-Oncology Certification
Dates: November 2–4, 2026
Start time: 10:00 AM on November 2
Location: Jl. Sunset Road No. 101E, Kuta, Bali
Language: English
Audience: Licensed physicians
Contact: info@stemcellsgroup.com
ISSCA Signature Bali: A new certification format backed by global experience
For 16 years, ISSCA has developed medical education and certification programs for the international regenerative medicine community.
More than 10,000 physicians across over 40 countries have participated in ISSCA certification initiatives.
ISSCA Signature extends that experience through a format centered on one city and one certification at a time. The Bali edition begins the series with a program connecting cellular therapeutics, peptide science and immuno-oncology in one three-day academic experience.
Request information about ISSCA Signature Bali
To receive additional information about ISSCA Signature — Bali and the Advanced Cellular Therapeutics & Immuno-Oncology Certification, contact the ISSCA team at info@stemcellsgroup.com.
ISSCA Signature — Bali
November 2–4, 2026 · 10:00 AM
Jl. Sunset Road No. 101E, Kuta, Bali
This content is intended for healthcare professionals and describes a medical education program. It does not constitute medical advice, a treatment recommendation or authorization to practice outside applicable laws and professional scope.
